OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

TSC2-mutant uterine sarcomas with JAZF1-SUZ12 fusions demonstrate hybrid features of endometrial stromal sarcoma and PEComa and are responsive to mTOR inhibition
Sarah Chiang, Varshini Vasudevaraja, Jonathan Serrano, et al.
Modern Pathology (2021) Vol. 35, Iss. 1, pp. 117-127
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

A Clinicopathologic and Molecular Characterization of Uterine Sarcomas Classified as Malignant PEComa
William J. Anderson, Fei Dong, Christopher D.�M. Fletcher, et al.
The American Journal of Surgical Pathology (2023) Vol. 47, Iss. 5, pp. 535-546
Open Access | Times Cited: 17

ESGO/EURACAN/GCIG guidelines for the management of patients with uterine sarcomas
Isabelle Ray‐Coquard, Paolo G. Casali, Sabrina Croce, et al.
International Journal of Gynecological Cancer (2024) Vol. 34, Iss. 10, pp. 1499-1521
Open Access | Times Cited: 7

The Spectrum of Fusions Occurring in Non–Smooth Muscle Mesenchymal Uterine Tumors: A Review of the Current Knowledge
Pavel Dundr, Radoslav Matěj, J. Hojný, et al.
Archives of Pathology & Laboratory Medicine (2024)
Open Access | Times Cited: 5

The Role of mTOR and eIF Signaling in Benign Endometrial Diseases
Tatiana S. Driva, Christoph Schatz, Monika Sobočan, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3416-3416
Open Access | Times Cited: 21

Uterine mesenchymal tumours harboring the KAT6B/A::KANSL1 gene fusion represent a distinct type of uterine sarcoma based on DNA methylation profiles
F. Kommoss, Alphonse Charbel, David L. Kolin, et al.
Virchows Archiv (2024) Vol. 485, Iss. 5, pp. 793-803
Open Access | Times Cited: 4

Malignant perivascular epithelioid cell tumor of the colorectum: Clinicopathological characterization, diagnosis and treatment process of 7 cases
Ming-Fei Ma, Zhikai Chi, Lijuan Zhao, et al.
World Journal of Gastrointestinal Oncology (2025) Vol. 17, Iss. 2
Closed Access

Isolation of proteins on chromatin (iPOC) reveals signaling pathway-dependent alterations in the DNA-bound proteome
Huiyu Wang, Syed Azmal Ali, Jeroen Krijgsveld, et al.
Molecular & Cellular Proteomics (2025), pp. 100908-100908
Open Access

Cathepsins and their role in gynecological cancers: Evidence from two-sample Mendelian randomization analysis
Xiaoying Li, Lingyi Sun, Xiaoting Wu, et al.
Medicine (2025) Vol. 104, Iss. 10, pp. e41653-e41653
Open Access

Targeted RNA Sequencing Highlights a Diverse Genomic and Morphologic Landscape in Low-grade Endometrial Stromal Sarcoma, Including Novel Fusion Genes
David L. Kolin, Marisa R. Nucci, Gulisa Turashvili, et al.
The American Journal of Surgical Pathology (2023) Vol. 48, Iss. 1, pp. 36-45
Closed Access | Times Cited: 8

Novel Therapeutics in the Treatment of Uterine Sarcoma
Sminu Bose, Gary K. Schwartz, Matthew Ingham
American Society of Clinical Oncology Educational Book (2022), Iss. 42, pp. 900-909
Open Access | Times Cited: 13

Genomic and Transcriptomic Characterization Revealed the High Sensitivity of Targeted Therapy and Immunotherapy in a Subset of Endometrial Stromal Sarcoma
Nan Kang, Yinli Zhang, Shichao Guo, et al.
Cancer Research and Treatment (2023) Vol. 55, Iss. 3, pp. 978-991
Open Access | Times Cited: 6

Expanding the molecular spectrum of gene fusions in endometrial stromal sarcoma: Novel subunits of the chromatin remodeling complexes PRC2 and NuA4/TIP60 as alternative fusion partners
Josephine K. Dermawan, Nooshin K. Dashti, Sarah Chiang, et al.
Genes Chromosomes and Cancer (2022) Vol. 62, Iss. 3, pp. 152-160
Open Access | Times Cited: 9

Feasibility of Longitudinal ctDNA Assessment in Patients with Uterine and Extra-Uterine Leiomyosarcoma
Maggie Zhou, Nam Q. Bui, Richa Rathore, et al.
Cancers (2022) Vol. 15, Iss. 1, pp. 157-157
Open Access | Times Cited: 6

Sarcomas With RAD51B Fusions Are Associated With a Heterogeneous Phenotype
Hsin‐Yi Chang, Josephine K. Dermawan, Aarti E. Sharma, et al.
Modern Pathology (2023) Vol. 37, Iss. 2, pp. 100402-100402
Closed Access | Times Cited: 3

Massive Malignant Epithelioid Angiomyolipoma of the Kidney
Isaac M. Tessone, Benjamin Lichtbroun, Arnav Srivastava, et al.
Journal of Kidney Cancer and VHL (2022) Vol. 9, Iss. 2, pp. 13-18
Open Access | Times Cited: 5

An Unusual Endometrial Stromal Neoplasm With JAZF1-BCORL1 Rearrangement
Parnian A. Moghaddam, Robert H. Young, Nadia Ismiil, et al.
International Journal of Gynecological Pathology (2023)
Closed Access | Times Cited: 2

Polycomb Repressive Complex 2 in Oncology
Yiran Guo, Yao Yu, Gang Greg Wang
Cancer treatment and research (2023), pp. 273-320
Closed Access | Times Cited: 2

Melanocytic marker expression and TSC alterations/TFE3 fusions in uterine PEComas
Robert A. Soslow
Modern Pathology (2022) Vol. 35, Iss. 4, pp. 449-450
Open Access | Times Cited: 4

Case report: Kidney perivascular epithelioid cell tumor treated with anti-VEGFR tyrosine kinase inhibitor and MTOR inhibitor
Ninggang Zhang, Yaqiong Ren, Likun Zan, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 4

Case report: Response to everolimus in a patient with platinum resistant, high grade serous ovarian carcinoma with biallelic TSC2 inactivation
Mariko S Peterson, David L. Kolin, Panagiotis A. Konstantinopoulos
Frontiers in Oncology (2024) Vol. 14
Open Access

Isolation of proteins on chromatin (iPOC) reveals signaling pathway-dependent alterations in the DNA-bound proteome
Huiyu Wang, Jeroen Krijgsveld, Gianluca Sigismondo
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Molecular basis of uterine mesenchymal tumours
Zarius Ferozepurwalla, Angela Ralte
Diagnostic histopathology (2024) Vol. 30, Iss. 9, pp. 487-498
Closed Access

Tumeurs mésenchymateuses utérines associées à translocation : du nouveau sans oublier l’ancien. Une approche diagnostique intégrée
Quitterie Fontanges, Nathalène Truffaux, Rihab Azmani, et al.
Annales de Pathologie (2024)
Closed Access

Case report: Responses to the combination of gemcitabine with sirolimus in two patients with TSC-mutated sarcomas
Elise F. Nassif, Cissimol P. Joseph, Rossana Lazcano, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 1

Primary uterine synovial sarcoma with SMARCA4 loss
Jennifer Pors, Kelly A. Devereaux, Daniella Hildebrandt, et al.
Histopathology (2022) Vol. 80, Iss. 7, pp. 1135-1137
Closed Access | Times Cited: 2

Page 1 - Next Page

Scroll to top